姚 远,许可葵,刘湘国.2009—2015年湖南省肿瘤登记地区恶性淋巴瘤发病与死亡分析[J].中国肿瘤,2020,29(9):663-671.
2009—2015年湖南省肿瘤登记地区恶性淋巴瘤发病与死亡分析
Incidence and Mortality of Malignant Lymphoma in the Registered Regions of Hunan Province,2009—2015
中文关键词  修订日期:2019-05-23
DOI:10.11735/j.issn.1004-0242.2020.09.A005
中文关键词:  肿瘤登记  恶性淋巴瘤  发病率  死亡率  湖南
英文关键词:cancer registration  malignant lymphoma  incidence  mortality  Hunan
基金项目:
作者单位
姚 远 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院 
许可葵 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院 
刘湘国 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院 
摘要点击次数: 1071
全文下载次数: 171
中文摘要:
      摘 要:[目的] 分析2009—2015年湖南省肿瘤登记地区恶性淋巴瘤发病、死亡情况。[方法]计算2009—2015年湖南省肿瘤登记地区恶性淋巴瘤的发病率、死亡率、0~74岁累积率、35~64岁截缩率等指标,标化率采用2000年全国人口普查标准人口和Segi’s世界标准人口构成作为标准。[结果] 2009—2015年湖南省24个肿瘤登记地区合计年中人口数为40 618 446人年,共收集新发恶性淋巴瘤病例2515例,恶性淋巴瘤死亡病例1554例。所有恶性淋巴瘤病例病理组织学诊断比例99.36%,只有死亡医学证明书比例0.64%,死亡/发病比为0.62。全省恶性淋巴瘤发病率6.19/10万,中标发病率为4.65/10万,世标发病率4.53/10万,0~74岁累积率为0.78%,35~64岁截缩发病率为7.74/10万。城区居民恶性淋巴瘤发病率高于农村,男性恶性淋巴瘤发病率高于女性,男性恶性淋巴瘤发病顺位居男性全部恶性肿瘤发病的第7位,女性居第9位。全省居民恶性淋巴瘤死亡率为3.83/10万,中标死亡率为2.71/10万,世标死亡率2.64/10万,0~74 岁累积率为0.56%,35~64岁截缩死亡率为4.21/10万。城市居民恶性淋巴瘤死亡率高于农村居民,男性高于女性,男性恶性淋巴瘤死亡顺位居男性全部恶性肿瘤死亡的第7位,女性居第9位。[结论] 恶性淋巴瘤是威胁湖南省居民身心健康的恶性肿瘤之一,应对高风险人群做好积极的防治工作。
英文摘要:
      Abstract:[Purpose] To analyze the incidence and mortality of malignant lymphoma in the registered regions of Hunan province in 2009—2015. [Methods] Descriptive analysis included incidence/mortality stratified by area,gender,and age group. Cumulative incidence/mortality rates(0~74 years old) and truncated rate between 35 and 64 years old were also calculated. The Chinese population census in 2000 and Segi’s world population were used for calculating the age-standardized cancer incidence/mortality rates.[Results] Twenty-four cancer registries in Hunan province in 2009—2015 covered 40 618 446 person years. The total new malignant lymphoma cases and malignant lymphoma deaths were 2515 and 1554 in 2009—2015,respectively. The morphology verified cases(MV%) accounted for 99.36%;and 0.64% of incident cases were identified through death certifications only(DCO%),with a mortality to incidence ratio of 0.62. The malignant lymphoma incidence in Hunan province was 6.19/105,the age-standardized incidence rates by Chinese standard population(ASR China) and by world standard population(ASR world) were 4.65/105 and 4.53/105 with the cumulative incidence rate(0~74 years old) of 0.78%,the truncated incidence(35~64 years old) were 7.74/105. The malignant lymphoma incidence was higher in urban areas than that in rural areas. The malignant lymphoma incidence was higher in males than that in females. Incidence of malignant lymphoma ranked the 7th among males and the 9th among females of all cancer deaths. The malignant lymphoma mortality in Hunan cancer registries in 2009—2015 was 3.83/105,the age-standardized mortality rates by Chinese standard population and by world standard population were 2.71/105 and 2.64/105,respectively,and the cumulative mortality rate(0~74 years old) was 0.56%,the truncated mortality(35~64 years old) were 4.21/105. The malignant lymphoma mortality was higher in urban areas than that in rural areas. The malignant lymphoma mortality was higher in men than that in women. Mortality of malignant lymphoma ranked the 7th among males and the 9th among females of all cancer deaths. [Conclusion]Malignant lymphoma is one of the malignant tumors threatening the physical and mental health of Hunan residents. Active
在线阅读   查看全文  查看/发表评论  下载PDF阅读器